A detailed history of Legal & General Group PLC transactions in Amgen Inc stock. As of the latest transaction made, Legal & General Group PLC holds 4,787,470 shares of AMGN stock, worth $1.41 Billion. This represents 0.33% of its overall portfolio holdings.

Number of Shares
4,787,470
Previous 4,787,470 -0.0%
Holding current value
$1.41 Billion
Previous $1.54 Billion -0.0%
% of portfolio
0.33%
Previous 0.33%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$309.38 - $337.38 $16 Million - $17.4 Million
-51,568 Reduced 1.07%
4,787,470 $1.54 Billion
Q2 2024

Aug 14, 2024

SELL
$262.75 - $319.31 $35.6 Million - $43.2 Million
-135,328 Reduced 2.72%
4,839,038 $1.51 Billion
Q1 2024

Jul 01, 2024

BUY
$268.87 - $324.56 $8.28 Million - $9.99 Million
30,792 Added 0.62%
4,974,366 $1.41 Billion
Q1 2024

May 14, 2024

SELL
$268.87 - $324.56 $21.7 Million - $26.2 Million
-80,599 Reduced 1.6%
4,943,574 $1.41 Billion
Q4 2023

Feb 15, 2024

BUY
$255.7 - $288.46 $246 Million - $278 Million
963,555 Added 23.73%
5,024,173 $1.45 Billion
Q3 2023

Nov 14, 2023

SELL
$218.65 - $271.46 $33.4 Million - $41.5 Million
-152,947 Reduced 3.63%
4,060,618 $1.09 Billion
Q2 2023

Aug 14, 2023

BUY
$214.27 - $253.37 $27.8 Million - $32.9 Million
129,681 Added 3.18%
4,213,565 $935 Million
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $3.86 Million - $4.71 Million
17,109 Added 0.42%
4,083,884 $987 Million
Q4 2022

Feb 14, 2023

SELL
$229.03 - $291.01 $43.2 Million - $54.9 Million
-188,750 Reduced 4.44%
4,066,775 $1.07 Billion
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $38.3 Million - $43.2 Million
-170,586 Reduced 3.85%
4,255,525 $959 Million
Q2 2022

Aug 22, 2022

SELL
$230.71 - $256.74 $23.7 Million - $26.4 Million
-102,706 Reduced 2.27%
4,426,111 $1.08 Billion
Q1 2022

May 16, 2022

BUY
$219.27 - $242.57 $54.3 Million - $60.1 Million
247,748 Added 5.79%
4,528,817 $1.1 Billion
Q4 2021

Feb 14, 2022

SELL
$198.88 - $227.6 $16.6 Million - $19 Million
-83,395 Reduced 1.91%
4,281,069 $963 Million
Q3 2021

Nov 15, 2021

BUY
$212.27 - $248.7 $31.1 Million - $36.5 Million
146,679 Added 3.48%
4,364,464 $928 Million
Q2 2021

Aug 12, 2021

BUY
$233.58 - $259.14 $57.1 Million - $63.4 Million
244,578 Added 6.16%
4,217,785 $1.03 Billion
Q1 2021

May 17, 2021

SELL
$221.91 - $258.6 $16.7 Million - $19.5 Million
-75,289 Reduced 1.86%
3,973,207 $989 Million
Q4 2020

Feb 12, 2021

BUY
$216.38 - $257.67 $10.7 Million - $12.8 Million
49,631 Added 1.24%
4,048,496 $931 Million
Q3 2020

Nov 13, 2020

SELL
$234.65 - $260.95 $5.67 Million - $6.3 Million
-24,154 Reduced 0.6%
3,998,865 $1.02 Billion
Q2 2020

Aug 14, 2020

BUY
$197.81 - $242.74 $30.5 Million - $37.4 Million
154,051 Added 3.98%
4,023,019 $949 Million
Q1 2020

May 14, 2020

BUY
$182.24 - $241.7 $7.51 Million - $9.96 Million
41,227 Added 1.08%
3,868,968 $785 Million
Q4 2019

Feb 13, 2020

SELL
$189.21 - $243.2 $500,649 - $643,507
-2,646 Reduced 0.07%
3,827,741 $923 Million
Q3 2019

Nov 13, 2019

SELL
$174.11 - $208.62 $1.52 Million - $1.82 Million
-8,723 Reduced 0.23%
3,830,387 $741 Million
Q2 2019

Aug 14, 2019

SELL
$166.7 - $195.41 $20.6 Million - $24.1 Million
-123,279 Reduced 3.11%
3,839,110 $707 Million
Q1 2019

May 15, 2019

BUY
$180.87 - $203.88 $130 Million - $147 Million
720,809 Added 22.24%
3,962,389 $753 Million
Q4 2018

Feb 15, 2019

BUY
$178.4 - $208.25 $31.1 Million - $36.3 Million
174,360 Added 5.68%
3,241,580 $631 Million
Q3 2018

Nov 20, 2018

SELL
$185.29 - $208.89 $2.3 Million - $2.6 Million
-12,434 Reduced 0.4%
3,067,220 $636 Million
Q2 2018

Aug 10, 2018

SELL
$166.05 - $186.51 $58.5 Million - $65.7 Million
-352,230 Reduced 10.26%
3,079,654 $568 Million
Q1 2018

May 17, 2018

SELL
$169.43 - $198.0 $45.9 Million - $53.7 Million
-271,116 Reduced 7.32%
3,431,884 $585 Million
Q4 2017

Feb 13, 2018

BUY
$168.79 - $188.59 $625 Million - $698 Million
3,703,000
3,703,000 $644 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.